전립선비대증에 대한 최소침습 수술적 치료의 효과 및 안전성에 대한 체계적 고찰

Abstract

Lower urinary tract symptoms caused by benign prostatic hyperplasia (BPH) has conventionally treated by transurethral resection of the prostate (TURP) or open simple prostatectomy. TURP has historically been associated with significant morbidity and then holmium laser enucleation of the prostate technique was developed and rapidly extended in global. Over recent years, novel minimally invasive surgical treatments (MISTs) such as the prostatic urethral lift (Urolift system), convective Water Vapor Energy (REZUM system), Aquablation (Aquabeam system) were entered to the field of BPH. MISTs aim to be effective, ideally to be performed in an outpatient setting under only local anesthesia and to offer a more favorable safety results than existing techniques. In present study, we provide an update on the more recently and largely studied about MISTs. The mechanism of action, efficacy and safety profiles about these MISTs in clinical trials were evaluated and presented.